MNPR - Monopar Therapeutics
48.77
0.820 1.681%
Share volume: 72,529
Last Updated: Wed 05 Feb 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.33%
PREVIOUS CLOSE
CHG
CHG%
$47.95
0.77
0.02%
Summary score
31%
Profitability
35%
Dept financing
5%
Liquidity
50%
Performance
30%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2020 - 30-Sep-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-20.92%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
18.35%
Debt ratio change over timeo
-0.98%
Current Ratio
6.45%
Quick Ratio
0%
Cash Position Ratio
5.67%
Short-term ratios 30-Sep-2023 - 30-Sep-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-23.35%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
18.43%
Debt ratio change over timeo
-0.98%
Current Ratio
5.59%
Quick Ratio
0%
Cash Position Ratio
5.14%
Last quarter ratios 30-Sep-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-23.13%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
18.5%
Debt ratio change over time
-0.98%
Current Ratio
5.41%
Quick Ratio
0%
Cash Position Ratio
5.36%
Performance ratios (change over 4 years) 30-Sep-2020 - 30-Sep-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
-102.2%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
-98%
Debt ratio change over time
-0.98%
Current Ratio
-0.31%
Quick Ratio
0%
Cash Position Ratio
-0.39%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MNPR | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | 0% | 16.27% | 18.34% | 4.17% |
| Return on assets | -20.92% | 2.36% | 3.17% | 5.68% |
| Return on sales | 0% | 28.88% | 30.73% | 42.61% |
| Return on invested capital | 0% | 2.59% | 5.33% | 28.42% |
| Profitability | 0% | 52% | 62% | 81% |
| Total debt ratio | 18.35% | 91.15% | 91.7% | 24.48% |
| Debt ratio change over time | -0.98% | 100.91% | 17.73% | -0% |
| Dept financing | 5% | 50% | 29% | 7% |
| Current Ratio | 5.59% | 0.8% | 1.33% | 3.12% |
| Quick Ratio | 0% | 0.69% | 0.94% | 2.88% |
| Cash Position Ratio | 5.14% | 0.31% | 0.46% | 2.2% |
| Liquididy | 50% | 10% | 20% | 55% |
| Short-term ratios | MNPR | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | -4.29% |
| Return on assets | -23.35% | 1.74% | 2.28% | 4.72% |
| Return on sales | 0% | 25.62% | 20.05% | 39.7% |
| Return on invested capital | 0% | 0% | 0% | -3.9% |
| Profitability | 50% | 25% | 25% | 50% |
| Total debt ratio | 18.43% | 95.21% | 93.27% | 25.36% |
| Debt ratio change over time | -0.98% | 0% | 0% | -0.58% |
| Dept financing | 5% | 25% | 49% | 7% |
| Current Ratio | 5.59% | 0.8% | 1.33% | 3.12% |
| Quick Ratio | 0% | 0.69% | 0.94% | 2.88% |
| Cash Position Ratio | 5.14% | 0.31% | 0.46% | 2.2% |
| Liquididy | 50% | 11% | 16% | 50% |